Olema Pharmaceuticals Inc. (OLMA) NASDAQ

$10.85 (0.01) (-0.09%)

Market Cap: $607.23M

As of 04/15/24 03:59 PM EDT. Market closed.

(OLMA)

Olema Pharmaceuticals Inc. (OLMA)
NASDAQ

$10.85
(0.01) (-0.09%)

Market Cap: $607.23M

As of 04/15/24 03:59 PM EDT. Market closed.

Add to Portfolio

olema oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. our lead program, op-1250, a potential best-in-class complete estrogen receptor antagonist (ceran), is in development to treat estrogen receptor-positive (er+), human epidermal growth factor receptor 2-negative (her2-) breast cancer. olema recently initiated a phase 1/2 dose-escalation ... read more

olema oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. our lead program, op-1250, a potential best-in-class complete estrogen receptor antagonist (ceran), is in development to treat estrogen receptor-positive (er+), human epidermal growth factor receptor 2-negative (her2-) breast cancer. olema recently initiated a phase 1/2 dose-escalation and expansion clinical trial of op-1250. we are supported in our mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies. for more information about the company please visit www.olema.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
83
Address
.
PRICE CHART FOR OLEMA PHARMACEUTICALS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$10.91
Previous Close
$10.86
Days Range
$10.66 - $11.72
52 week range
$3.55 - $17.79
Volume
676,249
Avg. Volume (30 days)
828,096
Market Cap
$607.23M
Dividend Yield
-
P/E
-
Shares Outstanding
55,914,741
Open
$10.91
Previous Close
$10.86
Days Range
$10.66 - $11.72
52 week range
$3.55 - $17.79
Volume
676,249
Avg. Volume (30 days)
828,096
Market Cap
$607.23M
Dividend Yield
-
P/E
-
Shares Outstanding
55,914,741
FINANCIAL STATEMENTS FOR OLEMA PHARMACEUTICALS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR OLEMA PHARMACEUTICALS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Harmon CyrusDirectorMar 28, 2024 Sale$10.9720,000219,400826,283Mar 29, 2024, 05:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERMar 18, 2024 Option Exercise$4.8713,70066,71980,364Mar 20, 2024, 05:30 PM
Harmon CyrusDirectorFeb 29, 2024 Sale$12.4125,000310,309846,383Mar 04, 2024, 05:30 PM
Harmon CyrusDirectorFeb 01, 2024 Sale$15.565,00077,800871,283Feb 02, 2024, 05:00 PM
Harmon CyrusDirectorJan 31, 2024 Sale$12.2325,000305,750876,283Feb 02, 2024, 05:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERJan 25, 2024 Option Exercise$7.0220,000140,40066,664Jan 29, 2024, 07:30 AM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Jan 12, 2024 Option Exercise$7.0250,000351,000484,987Jan 16, 2024, 07:30 AM
Harmon CyrusDirectorDec 29, 2023 Sale$13.3825,000334,500903,783Jan 02, 2024, 05:30 PM
Graham G. WalmsleyDirectorDec 05, 2023 Buy$14.19131,8701,871,2801,800,000Dec 18, 2023, 06:30 PM
Graham G. WalmsleyDirectorSep 12, 2023 Buy$9.84508,1304,999,9991,668,130Dec 18, 2023, 06:30 PM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Dec 12, 2023 Option Exercise$7.0210,00070,200434,987Dec 12, 2023, 05:55 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERDec 11, 2023 Option Exercise$7.022,90020,35846,664Dec 12, 2023, 05:55 PM
Paradigm Biocapital Advisors LP10% OwnerDec 06, 2023 Buy$11.60100,0001,160,0006,590,981Dec 08, 2023, 04:19 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERDec 06, 2023 Option Exercise$7.0213,10091,96243,764Dec 07, 2023, 08:30 PM
Harmon CyrusDirectorNov 30, 2023 Sale$12.5725,000314,250926,283Dec 01, 2023, 05:15 PM
Harmon CyrusDirectorNov 21, 2023 Sale$14.864,19262,293955,272Nov 22, 2023, 07:00 PM
Harmon CyrusDirectorNov 22, 2023 Sale$13.903,98955,447951,283Nov 22, 2023, 07:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERNov 22, 2023 Sale$13.897,09598,55030,664Nov 22, 2023, 07:00 PM
Zojwalla NaseemCHIEF MEDICAL OFFICERNov 21, 2023 Sale$14.847,461110,74737,959Nov 22, 2023, 07:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 22, 2023 Sale$13.896,65392,410574,099Nov 22, 2023, 07:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 21, 2023 Sale$14.886,976103,823580,952Nov 22, 2023, 07:00 PM
Bohen SeanPRESIDENT AND CEONov 21, 2023 Sale$14.8829,293435,879175,459Nov 22, 2023, 07:00 PM
Bohen SeanPRESIDENT AND CEONov 22, 2023 Sale$13.9027,932388,255144,925Nov 22, 2023, 07:00 PM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Nov 22, 2023 Sale$13.899,145127,024424,987Nov 22, 2023, 07:00 PM
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.Nov 21, 2023 Sale$14.869,597142,632434,832Nov 22, 2023, 07:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 08, 2023 Sale$17.612003,522561,270Nov 13, 2023, 05:30 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 03, 2023 Sale$17.515419,473561,470Nov 03, 2023, 09:39 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 02, 2023 Sale$15.363,33251,180562,011Nov 03, 2023, 09:39 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFNov 01, 2023 Sale$15.026,668100,153565,343Nov 03, 2023, 09:39 PM
Harmon CyrusDirectorOct 31, 2023 Sale$12.0525,000301,250948,714Nov 02, 2023, 08:50 PM
Harmon CyrusDirectorNov 02, 2023 Sale$15.645,00078,200943,714Nov 02, 2023, 08:50 PM
Harmon CyrusDirectorSep 29, 2023 Sale$12.4125,000310,250973,714Oct 03, 2023, 05:00 PM
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFSep 19, 2023 Sale$12.6720,000253,400572,011Sep 21, 2023, 05:00 PM
BVF PARTNERS L P/ILDirectorSep 12, 2023 Buy$9.841,505,93214,818,3714,688,954Sep 14, 2023, 04:25 PM
Harmon CyrusDirectorSep 05, 2023 Sale$11.6210,000116,200998,714Sep 05, 2023, 09:08 PM
Harmon CyrusDirectorAug 31, 2023 Sale$9.3615,000140,4001,008,714Sep 05, 2023, 09:08 PM
Harmon CyrusDirectorAug 16, 2023 Sale$10.1415,000152,1001,023,714Sep 05, 2023, 04:05 PM
Harmon CyrusDirectorAug 16, 2023 Sale$10.1415,000152,1001,023,714Aug 17, 2023, 05:00 PM
Harmon CyrusDirectorJun 08, 2023 Sale$6.3010,00063,0001,038,714Jun 09, 2023, 05:30 PM
Harmon CyrusDirectorJun 06, 2023 Sale$6.305,00031,4751,048,714Jun 07, 2023, 09:30 PM
Harmon CyrusDirectorJun 05, 2023 Sale$6.055,00030,2251,053,714Jun 07, 2023, 09:30 PM
BVF PARTNERS L P/ILDirectorJun 10, 2022 Buy$4.03200,000806,9003,913,676Jun 14, 2022, 04:46 PM
Horn KinneyCHIEF BUSINESS OFFICERMar 10, 2022 Option Exercise$2.065,25310,8427,711Mar 14, 2022, 04:45 PM
Horn KinneyCHIEF BUSINESS OFFICERMar 10, 2022 Sale$4.755,25324,9522,458Mar 14, 2022, 04:45 PM
Horn KinneyCHIEF BUSINESS OFFICERFeb 10, 2022 Option Exercise$2.065,25110,8387,709Feb 14, 2022, 05:18 PM
Horn KinneyCHIEF BUSINESS OFFICERJan 10, 2022 Option Exercise$2.065,25110,8387,709Jan 11, 2022, 08:21 PM
Horn KinneyCHIEF BUSINESS OFFICERJan 10, 2022 Sale$6.855,25135,9692,458Jan 11, 2022, 08:21 PM
Horn KinneyCHIEF BUSINESS OFFICERDec 10, 2021 Option Exercise$2.065,25110,8387,709Dec 14, 2021, 04:25 PM
Horn KinneyCHIEF BUSINESS OFFICERDec 10, 2021 Sale$10.395,25154,5582,458Dec 14, 2021, 04:25 PM
Myles David C.CHIEF DEVELOPMENT OFFICERDec 10, 2021 Sale$10.3010,000103,000582,901Dec 14, 2021, 04:03 PM
BVF PARTNERS L P/ILDirectorNov 30, 2021 Buy$9.39739,6756,945,7703,755,093Dec 02, 2021, 08:45 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERNov 29, 2021 Sale$24.764009,9041,051,146Dec 01, 2021, 05:34 PM
Horn KinneyCHIEF BUSINESS OFFICERNov 10, 2021 Option Exercise$15.7927,668436,76129,458Nov 12, 2021, 05:15 PM
Horn KinneyCHIEF BUSINESS OFFICERNov 10, 2021 Sale$26.8827,668743,7161,790Nov 12, 2021, 05:15 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICEROct 19, 2021 Sale$27.9812,000335,7941,056,101Oct 21, 2021, 04:33 PM
Bohen SeanPRESIDENT AND CEOOct 14, 2021 Option Exercise$4.825,00024,12057,514Oct 15, 2021, 06:44 PM
Bohen SeanPRESIDENT AND CEOOct 14, 2021 Sale$30.475,000152,36352,865Oct 15, 2021, 06:44 PM
Horn KinneyCHIEF BUSINESS OFFICEROct 11, 2021 Option Exercise$2.065,25110,8387,041Oct 12, 2021, 06:53 PM
Horn KinneyCHIEF BUSINESS OFFICEROct 11, 2021 Sale$27.905,251146,5104,936Oct 12, 2021, 06:53 PM
Bohen SeanPRESIDENT AND CEOSep 27, 2021 Option Exercise$4.821,0855,23453,599Sep 29, 2021, 07:56 PM
Bohen SeanPRESIDENT AND CEOSep 27, 2021 Sale$30.071,08532,62652,514Sep 29, 2021, 07:56 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERSep 20, 2021 Sale$26.3012,000315,6001,063,546Sep 21, 2021, 06:19 PM
Horn KinneyCHIEF BUSINESS OFFICERSep 10, 2021 Option Exercise$2.065,25110,8387,041Sep 13, 2021, 08:07 PM
Horn KinneyCHIEF BUSINESS OFFICERSep 10, 2021 Sale$29.385,251154,2741,790Sep 13, 2021, 08:07 PM
Bohen SeanPRESIDENT AND CEOSep 08, 2021 Option Exercise$4.822,63112,69256,905Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 07, 2021 Option Exercise$4.824131,99254,687Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 08, 2021 Sale$30.002,63178,93052,514Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 07, 2021 Sale$30.0841312,42354,274Sep 09, 2021, 04:25 PM
Bohen SeanPRESIDENT AND CEOSep 01, 2021 Option Exercise$4.828714,20255,145Sep 03, 2021, 05:16 PM
Bohen SeanPRESIDENT AND CEOSep 01, 2021 Sale$30.0587126,17454,274Sep 03, 2021, 05:16 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERAug 19, 2021 Sale$24.9712,000299,6401,075,546Aug 20, 2021, 09:14 PM
Horn KinneyCHIEF BUSINESS OFFICERAug 10, 2021 Option Exercise$2.065,25110,8387,041Aug 11, 2021, 06:05 PM
Horn KinneyCHIEF BUSINESS OFFICERAug 10, 2021 Sale$25.715,251134,9791,850Aug 11, 2021, 06:05 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERJul 20, 2021 Sale$25.634,123105,6721,087,546Jul 21, 2021, 05:29 PM
Harmon CyrusCHIEF TECHNOLOGY OFFICERJul 19, 2021 Sale$24.837,877195,5861,091,669Jul 21, 2021, 05:29 PM
Horn KinneyCHIEF BUSINESS OFFICERJul 12, 2021 Option Exercise$2.065,25110,8387,041Jul 13, 2021, 06:27 PM
Horn KinneyCHIEF BUSINESS OFFICERJul 12, 2021 Sale$26.515,251139,1913,182Jul 13, 2021, 06:27 PM
Horn KinneyCHIEF BUSINESS OFFICERMay 18, 2021 Option Exercise$2.0657,763119,22359,553May 19, 2021, 08:18 PM
Horn KinneyCHIEF BUSINESS OFFICERMay 18, 2021 Sale$24.1557,7631,394,76910,411May 19, 2021, 08:18 PM
Cormorant Asset Management, LPFormer 10% OwnerNov 23, 2020 Buy$19.00425,0008,075,0003,270,544Nov 23, 2020, 04:59 PM
Graham G. WalmsleyDirectorNov 23, 2020 Buy$19.001,160,00022,040,0001,160,000Nov 23, 2020, 04:35 PM
BVF PARTNERS L P/ILDirectorNov 19, 2020 Buy$19.001,135,33421,571,3463,392,663Nov 20, 2020, 08:02 PM
BUTITTA CYNTHIA MDirectorSep 16, 2020 Option Exercise$4.4183,876369,55883,876Nov 19, 2020, 06:42 PM
Bohen SeanPresident and CEOSep 23, 2020 Option Exercise$4.8251,649249,15551,649Nov 19, 2020, 06:41 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Harmon CyrusDirector03/28/2024219,400
Zojwalla NaseemCHIEF MEDICAL OFFICER03/18/202466,719
Harmon CyrusDirector02/29/2024310,309
Harmon CyrusDirector02/01/202477,800
Harmon CyrusDirector01/31/2024305,750
Zojwalla NaseemCHIEF MEDICAL OFFICER01/25/2024140,400
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.01/12/2024351,000
Harmon CyrusDirector12/29/2023334,500
Graham G. WalmsleyDirector12/05/20231,871,280
Graham G. WalmsleyDirector09/12/20234,999,999
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.12/12/202370,200
Zojwalla NaseemCHIEF MEDICAL OFFICER12/11/202320,358
Paradigm Biocapital Advisors LP10% Owner12/06/20231,160,000
Zojwalla NaseemCHIEF MEDICAL OFFICER12/06/202391,962
Harmon CyrusDirector11/30/2023314,250
Harmon CyrusDirector11/21/202362,293
Harmon CyrusDirector11/22/202355,447
Zojwalla NaseemCHIEF MEDICAL OFFICER11/22/202398,550
Zojwalla NaseemCHIEF MEDICAL OFFICER11/21/2023110,747
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/22/202392,410
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/21/2023103,823
Bohen SeanPRESIDENT AND CEO11/21/2023435,879
Bohen SeanPRESIDENT AND CEO11/22/2023388,255
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.11/22/2023127,024
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.11/21/2023142,632
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/08/20233,522
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/03/20239,473
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/02/202351,180
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF11/01/2023100,153
Harmon CyrusDirector10/31/2023301,250
Harmon CyrusDirector11/02/202378,200
Harmon CyrusDirector09/29/2023310,250
Myles David C.CH. DISCOV. & NON-CLIN DEV OFF09/19/2023253,400
BVF PARTNERS L P/ILDirector09/12/202314,818,371
Harmon CyrusDirector09/05/2023116,200
Harmon CyrusDirector08/31/2023140,400
Harmon CyrusDirector08/16/2023152,100
Harmon CyrusDirector08/16/2023152,100
Harmon CyrusDirector06/08/202363,000
Harmon CyrusDirector06/06/202331,475
Harmon CyrusDirector06/05/202330,225
BVF PARTNERS L P/ILDirector06/10/2022806,900
Horn KinneyCHIEF BUSINESS OFFICER03/10/202210,842
Horn KinneyCHIEF BUSINESS OFFICER03/10/202224,952
Horn KinneyCHIEF BUSINESS OFFICER02/10/202210,838
Horn KinneyCHIEF BUSINESS OFFICER01/10/202210,838
Horn KinneyCHIEF BUSINESS OFFICER01/10/202235,969
Horn KinneyCHIEF BUSINESS OFFICER12/10/202110,838
Horn KinneyCHIEF BUSINESS OFFICER12/10/202154,558
Myles David C.CHIEF DEVELOPMENT OFFICER12/10/2021103,000
BVF PARTNERS L P/ILDirector11/30/20216,945,770
Harmon CyrusCHIEF TECHNOLOGY OFFICER11/29/20219,904
Horn KinneyCHIEF BUSINESS OFFICER11/10/2021436,761
Horn KinneyCHIEF BUSINESS OFFICER11/10/2021743,716
Harmon CyrusCHIEF TECHNOLOGY OFFICER10/19/2021335,794
Bohen SeanPRESIDENT AND CEO10/14/202124,120
Bohen SeanPRESIDENT AND CEO10/14/2021152,363
Horn KinneyCHIEF BUSINESS OFFICER10/11/202110,838
Horn KinneyCHIEF BUSINESS OFFICER10/11/2021146,510
Bohen SeanPRESIDENT AND CEO09/27/20215,234
Bohen SeanPRESIDENT AND CEO09/27/202132,626
Harmon CyrusCHIEF TECHNOLOGY OFFICER09/20/2021315,600
Horn KinneyCHIEF BUSINESS OFFICER09/10/202110,838
Horn KinneyCHIEF BUSINESS OFFICER09/10/2021154,274
Bohen SeanPRESIDENT AND CEO09/08/202112,692
Bohen SeanPRESIDENT AND CEO09/07/20211,992
Bohen SeanPRESIDENT AND CEO09/08/202178,930
Bohen SeanPRESIDENT AND CEO09/07/202112,423
Bohen SeanPRESIDENT AND CEO09/01/20214,202
Bohen SeanPRESIDENT AND CEO09/01/202126,174
Harmon CyrusCHIEF TECHNOLOGY OFFICER08/19/2021299,640
Horn KinneyCHIEF BUSINESS OFFICER08/10/202110,838
Horn KinneyCHIEF BUSINESS OFFICER08/10/2021134,979
Harmon CyrusCHIEF TECHNOLOGY OFFICER07/20/2021105,672
Harmon CyrusCHIEF TECHNOLOGY OFFICER07/19/2021195,586
Horn KinneyCHIEF BUSINESS OFFICER07/12/202110,838
Horn KinneyCHIEF BUSINESS OFFICER07/12/2021139,191
Horn KinneyCHIEF BUSINESS OFFICER05/18/2021119,223
Horn KinneyCHIEF BUSINESS OFFICER05/18/20211,394,769
Cormorant Asset Management, LPFormer 10% Owner11/23/20208,075,000
Graham G. WalmsleyDirector11/23/202022,040,000
BVF PARTNERS L P/ILDirector11/19/202021,571,346
BUTITTA CYNTHIA MDirector09/16/2020369,558
Bohen SeanPresident and CEO09/23/2020249,155
Load More Insider Transactions
FUNDS WITH A POSITION IN OLEMA PHARMACEUTICALS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.3,263,9070.00117%45.52%Other
VIVO CAPITAL, LLC1,873,7042.15%No changeOther
GEODE CAPITAL MANAGEMENT, LLC824,8330.00121%25.78%Other
ADAGE CAPITAL PARTNERS GP, L.L.C.500,0000.01%28.54%Other
CANDRIAM S.C.A.215,0080.02%NewOther
RENAISSANCE TECHNOLOGIES LLC173,6110.00377%-44.09%Other
ALPS ADVISORS INC38,1630.00421%NewOther
D. E. SHAW & CO., INC.11,8890.00015%NewOther
AQR CAPITAL MANAGEMENT LLC10,7810.00028%7.24%Other
CHANGE IN SHARES OUTSTANDING FOR OLEMA PHARMACEUTICALS INC
STOCK BUYBACKS FOR OLEMA PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.60%
1Q
12/31/2023
06/30/2023
11.12%
2Q
12/31/2023
03/31/2023
12.12%
3Q
12/31/2023
12/31/2022
12.58%
4Q
12/31/2023
09/30/2022
13.02%
5Q
12/31/2023
06/30/2022
13.35%
6Q
12/31/2023
03/31/2022
13.59%
7Q
12/31/2023
12/31/2021
13.84%
8Q
12/31/2023
09/30/2021
14.24%
9Q
12/31/2023
06/30/2021
14.80%
10Q
12/31/2023
03/31/2021
15.06%
11Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.60%
1Q
06/30/2023
11.12%
2Q
03/31/2023
12.12%
3Q
12/31/2022
12.58%
4Q
09/30/2022
13.02%
5Q
06/30/2022
13.35%
6Q
03/31/2022
13.59%
7Q
12/31/2021
13.84%
8Q
09/30/2021
14.24%
9Q
06/30/2021
14.80%
10Q
03/31/2021
15.06%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR OLEMA PHARMACEUTICALS INC
LOADING...